We are live on ! Find out more
OC

Oppenheimer & Co Portfolio holdings

AUM $9.37B
1-Year Est. Return 36.4%
This Fund
S&P 500
This Quarter Est. Return
+8.78%
1 Year Est. Return
+36.4%
3 Year Est. Return
+114.29%
5 Year Est. Return
+137.63%
10 Year Est. Return
+535.77%
AUM
$3.13B
AUM Growth
+$281M
Cap. Flow
+$61.6M
Cap. Flow %
1.97%
Top 10 Hldgs %
12.2%
Holding
1,543
New
228
Increased
546
Reduced
510
Closed
166

Sector Composition

Rank Sector Weight
1 Energy 12.37%
2 Healthcare 10.59%
3 Industrials 9.5%
4 Financials 9.49%
5 Technology 9.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GAB icon
1276
Gabelli Equity Trust
GAB
$1.79B
$134K ﹤0.01%
18,290
+467
+3% +$3.16K
DZSI
1277
DELISTED
DZS Inc. Common Stock
DZSI
$134K ﹤0.01%
5,000
NYNY
1278
DELISTED
Empire Resorts, Inc.
NYNY
$134K ﹤0.01%
5,520
MEA
1279
DELISTED
METALICO INC
MEA
$134K ﹤0.01%
64,600
-6,000
-8% -$10.2K
DS
1280
DELISTED
Drive Shack Inc.
DS
$132K ﹤0.01%
25,521
-264,306
-91% -$1.33M
VLY icon
1281
Valley National Bancorp
VLY
$8.04B
$131K ﹤0.01%
12,989
-203
-2% -$2.04K
ROSG
1282
DELISTED
Rosetta Genomics Ltd.
ROSG
$131K ﹤0.01%
3,750
DEX
1283
DELISTED
DELAWARE ENHANCED GLOBAL DIVIDEND & INCOME FUND
DEX
$130K ﹤0.01%
10,632
-2,998
-22% -$36.4K
ACFC
1284
DELISTED
Atlantic Coast Financial Corporation
ACFC
$130K ﹤0.01%
+30,000
New +$115K
XCO
1285
DELISTED
Exco Resources
XCO
$130K ﹤0.01%
1,633
-558
-25% -$47.6K
ATTU
1286
DELISTED
Attunity Ltd
ATTU
$130K ﹤0.01%
+12,500
New +$113K
AH
1287
DELISTED
Accretive Health
AH
$129K ﹤0.01%
14,100
+100
+0.7% +$861
PLUR icon
1288
Pluri
PLUR
$19.6M
$128K ﹤0.01%
456
+13
+3% +$3.49K
PCK
1289
DELISTED
Pimco California Municipal Income Fund II
PCK
$127K ﹤0.01%
+14,079
New +$131K
TAT
1290
DELISTED
TransAtlantic Petroleum LTD.
TAT
$126K ﹤0.01%
14,728
-3,828
-21% -$31K
OXGN
1291
DELISTED
OXIGENE INC COM
OXGN
$126K ﹤0.01%
+50,000
New +$134K
NTS
1292
DELISTED
NTS INC COM STK (NV)
NTS
$125K ﹤0.01%
+63,278
New +$119K
NQS
1293
DELISTED
NUVEEN SELECT QUALITY MUNI FD
NQS
$125K ﹤0.01%
+10,074
New +$124K
NBIX icon
1294
Neurocrine Biosciences
NBIX
$16.6B
$124K ﹤0.01%
+13,200
New +$129K
IGD
1295
Voya Global Equity Dividend and Premium Opportunity Fund
IGD
$517M
$123K ﹤0.01%
13,685
-1,942
-12% -$17.4K
VIVS
1296
VivoSim Labs
VIVS
$1.64M
$122K ﹤0.01%
46
-94
-67% -$185K
ACH
1297
DELISTED
Alum Corp of China Ltd
ACH
$122K ﹤0.01%
14,000
-2,500
-15% -$22.7K
PDLI
1298
DELISTED
PDL BioPharma, Inc.
PDLI
$122K ﹤0.01%
14,400
-3,000
-17% -$25.3K
AUDC icon
1299
AudioCodes
AUDC
$253M
$121K ﹤0.01%
+17,000
New +$112K
JGG
1300
DELISTED
NUVEEN GLOBAL INCOME OPPORTUNITIES FUND
JGG
$121K ﹤0.01%
10,586
-6,548
-38% -$75.9K

Similar funds

Oppenheimer & Co's Q4 2013 Portfolio in Review

As of Q4 2013, Oppenheimer & Co held 1,543 positions worth $3.13B, up 9.9% from $2.84B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Oppenheimer & Co's Q4 2013 filing shows 228 new, 546 increased, 510 reduced and 166 closed positions. Its largest new stake was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M. The largest sale was WisdomTree Emerging Markets Local Debt Fund, an estimated $5.52M.

By sector, the portfolio is most concentrated in Energy at 12% of assets, down from 13% a quarter earlier, followed by Healthcare and Industrials.

  • Oppenheimer & Co's largest Q4 2013 buy was TetraLogic Pharmaceuticals Corporation: 1,072,115 shares worth $10.2M.
  • Oppenheimer & Co added most to Invesco FTSE RAFI US 1000 ETF in Q4 2013, an estimated $8.14M increase.
  • Oppenheimer & Co's biggest Q4 2013 reduction was WisdomTree Emerging Markets Local Debt Fund, cutting an estimated $5.52M.
  • Oppenheimer & Co fully exited iShares Global Financials ETF in Q4 2013, selling an estimated $5.36M.
  • Oppenheimer & Co's ten largest holdings make up 12% of its $3.13B portfolio in Q4 2013.
  • Oppenheimer & Co opened 228 new positions and closed 166 in Q4 2013.
  • Oppenheimer & Co's portfolio value rose 9.9% quarter-over-quarter to $3.13B.

Based on Oppenheimer & Co's 13F filing for Q4 2013, filed 12 Feb 2014.